AN2 Therapeutics, Inc. (ANTX)

4.64 -0.10 (-2.11%) USD  |  NASDAQ  |  Apr 29, 14:22
More

AN2 Therapeutics EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade